Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy (2019)
Update date:2022-08-11
Topics:
Zhao, Baojuan
Wang, Minzhen
Wang
Yu, Pengfei
Wang, Na
Li, Fengjuan
A series of novel porphyrin-cinnamic acid (porphyrin/CA) conjugates (4a-4c) have been synthesized by condensation of 5-(4-Hydroxyphenyl)-10,15,20-triphenyl- porphyrin (1) with different substituted cinnamic acids (CAs) through an alkyl linker due to the biological activities of CAs and the application of porphyrins in photodynamic therapy (PDT) of cancer. Their related zinc (II) complexes (5a-5c) were also prepared. These novel compounds have been fully characterized by 1H NMR, Infrared (IR), Mass spectra (Ms) and Elemental analysis. The photophysical properties of these target molecules were studied by absorption and Fluorescence spectroscopy. In solution, the effect of pH, ionic strength in acid media and concentration on the aggregation behaviors of 4a has also been investigated by UV–Vis spectra. The broadened and red shifted Soret band indicated the formation of J-aggregates when the pH value was up to 2.0 in THF-aqueous solution. Furthermore, the higher ionic strength of 0.3 M NaCl in acid media resulted in the generation of J-aggregates in THF-aqueous solution. And the significant blue shift of Soret band also demonstrated the formation of H-aggregates of 4a at 1.1 × 10?4 M in THF.
View MoreContact:+86-532-80762375
Address:No. 6, Hongkong Middle Road, Qingdao, China
Contact:+86-18200374913
Address:Hongmei Road, No. 99
TIANJIN NORTH JINHENG CHEMICAL PLANT.
Contact:0086-22-59952083
Address:DongShigu Country In JiXian TianJin China
Changzhou LanXu Chemical Co.,ltd.(expird)
Contact:86-0519-86330911,13656129734,15261186386
Address:Room 524, Depart.Chemical, Changzhou Science and Eductaion town, Jiangsu, China;Factory: Haian Fine Chemical Industry Park,Nantong,Jiangsu,China
Contact:+86-575-82733999 0575-82732999
Address:hangzhou gulf fine chemical zone,shangyu city,zhejiang province
Doi:10.1021/ja01164a055
(1950)Doi:10.1016/0040-4020(95)00384-K
(1995)Doi:10.1016/S0022-328X(00)92349-0
(1979)Doi:10.1055/s-2004-815410
(2004)Doi:10.1016/S0040-4020(99)00470-6
(1999)Doi:10.1021/acs.molpharmaceut.0c00917
(2021)